Characteristics | Pre-intervention | Post-intervention | P value |
(n=100) | (n=102) | ||
Age (years) (mean (SD)) | 62 (10.6) | 59 (10.5) | 0.038 |
Body mass index (mean (SD)) | 32 (9.5) | 32 (9.2) | 0.8 |
Charlson comorbidity index (n (%)) | 0.54 | ||
0 | 14 (14) | 16 (16) | |
1 | 19 (19) | 27 (26) | |
2 | 33 (33) | 30 (29) | |
≥3 | 34 (34) | 29 (28) | |
Previous abdominal surgery (n (%)) | 56 (56) | 44 (43) | 0.092 |
Preoperative diagnosis (n (%)) | |||
Uterine cancer | 85 (85) | 72 (71) | 0.015 |
Ovarian cancer | 1 (1) | 10 (10) | |
Cervical cancer | 3 (3) | 3 (3) | |
Ovarian neoplasm (benign/borderline) | 11 (11) | 15 (15) | |
Other | 0 | 2 (2)* | |
MIS approach (n (%)) | |||
Laparoscopic | 63 (63) | 81 (79) | 0.015 |
Robotic | 37 (37) | 21 (21) | |
Nodal assessment (n (%)) | |||
None | 26 (26) | 29 (28) | 0.17 |
Sentinel node assessment | 43 (43) | 51 (50) | |
Full lymphadenectomy | 31 (31) | 22 (22) | |
Order of case (n (%)) | |||
First case of the day | 70 (70) | 61 (60) | 0.16 |
Second or third case of the day | 30 (30) | 41 (40) | |
Length of surgery (min) (mean (SD)) | 211 (68.8) | 180 (59.7) | <0.001 |
Conversion to laparotomy (n (%)) | 8 (8) | 1 (1) | 0.018 |
Intraoperative transfusions (n (%)) | 2 (2) | 2 (2) | 1 |
Intraoperative complications (n (%)) | 1 (1) | 3 (3) | 0.62 |
Blood loss (mL) (median (range)) | 0 (0–500) | 50 (0–800) | 0.33 |
Final FIGO stage (n (%)) | |||
Benign/borderline | 1 (1) | 19 (19) | <0.001 |
1 | 80 (80) | 64 (63) | |
2 | 15 (15) | 11 (11) | |
3 | 3 (3) | 7 (7) | |
4 | 1 (1) | 1 (1) | |
Uterine weight (g) (median (range)) | 117 (45–298) | 120 (11–641) | 0.34 |
*Other refers to one case of myometrium lipoleiomyoma and another case of cervical spindle cell proliferation not otherwise classified
SD, standard deviation; MIS, minimally invasive surgery; FIGO, International Federation of Gynecology and Obstetrics.